Viking Therapeutics, Inc. (VKTX): Debt Offering News

VKTX – Files for $450 mln mixed securities shelf offering.


Key Facts Surrounding This News Item


  • VKTX had a POWR Rating of C (Neutral) coming into today.
  • VKTX was -3.15% below its 10-Day Moving Average coming into today.
  • VKTX was -9.73% below its 20-Day Moving Average coming into today.
  • VKTX was 22.54% above its 50-Day Moving Average coming into today.
  • VKTX was 47.27% above its 100-Day Moving Average coming into today.
  • VKTX was 90.88% above its 200-Day Moving Average coming into today.
  • VKTX had returned +138.92% year-to-date leading up to today’s news, versus a +5.40% return from the benchmark S&P 500 during the same period.

More Info About Viking Therapeutics, Inc. (VKTX)


Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead clinical program, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in Phase II development for the treatment of patients recovering from non-elective hip fracture surgery; in Phase I clinical trials for improving lean body mass; and in pre-clinical trial for improving bone mineral density, bone mineral content, bone strength, and other measures. The company is also developing VK2809, an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in a Phase II clinical trial for the treatment of patients with hypercholesterolemia and fatty liver disease; and in a Phase I clinical trial to treat patients who suffer from glycogen storage disease type Ia. In addition, it is developing VK0214 for X-linked adrenoleukodystrophy, which is in pre-clinical stage. Viking Therapeutics, Inc. was founded in 2012 and is based in San Diego, California. View our full VKTX ticker page with ratings, news, and more.

VKTX at a Glance

VKTX Current POWR Rating™
Overall POWR Rating™
VKTX Current Price $8.99 3.44%
More VKTX Ratings, Data, and News

VKTX Price Reaction

The day of this event (Jul. 11, 2018)
VKTX Closing Price$10.00 3.09%
VKTX Volume1,785,200
15.70% from avg
Leading up to this event
VKTX 1-mo return8.66%
After this event
VKTX 1-day return6.37%
VKTX 3-day return10.68%
VKTX 5-day return3.00%

VKTX Price Chart


The Top Stocks For 2019

More Viking Therapeutics, Inc. (VKTX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VKTX News
Page generated in 0.8502 seconds.